Optimize Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Optimize Financial's BMY Position: Q3 2026 in Review
Optimize Financial opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 7,208 shares worth $450K. The stake represents 0.09% of the portfolio and ranks #200 among its holdings. This is a return to the name: Optimize Financial previously reported a position in BMY as recently as Q4 2025.
Optimize Financial first reported a position in BMY in Q3 2025 and has held it in 3 quarters since. The position peaked at $493K in Q4 2025. 2,555 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Optimize Financial held 7,208 shares of Bristol-Myers Squibb worth $450K as of Q3 2026.
- Bristol-Myers Squibb was a new Optimize Financial position in Q3 2026.
- Bristol-Myers Squibb made up 0.09% of Optimize Financial's portfolio in Q3 2026, its #200 holding.
- Optimize Financial first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 3 quarters since.
- Optimize Financial's Bristol-Myers Squibb position peaked at $493K in Q4 2025.
- 2,555 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Optimize Financial's 13F filing for Q3 2026, filed 12 Nov 2026.